In-silico heart model for cardiotoxicity and drug studies
Companymyofarm, Göttingen, Germany
The company myofarm has developed a platform for high-throughput analysis of cardiac, three-dimensional microtissue. The platform enables multiparametric measurements without damaging heart tissue cultured from human inductive pluripotent stem cells (hiPS). In this way, short-term as well as long-term interactions between the active substances to be tested and the excitation-contraction coupling of the mini-heart can be assessed. The measurement data obtained is fed into an AI-based database, which researchers can use to plan and carry out laboratory-independent cardiotoxicity tests and preclinical drug studies.
myofarm for a better and animal-free drug development
hello@myofarm.de
Added on: 08-08-2023
[1] https://myofarm.de/[2] https://snic.de/myofarm/